ScanSource (SCSC) Financials

ScanSource logo
$46.65 +0.64 (+1.39%)
Closing price 11/19/2026 04:00 PM Eastern
Extended Trading
$47.15 +0.50 (+1.07%)
As of 11/19/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for ScanSource

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
64 69 33 58 -193 11 89 90 77 72 79
Consolidated Net Income / (Loss)
64 69 33 58 -193 11 89 90 77 72 79
Net Income / (Loss) Continuing Operations
64 69 35 65 -79 45 89 88 77 72 79
Total Pre-Tax Income
96 101 63 84 -72 58 119 122 100 94 104
Total Operating Income
97 88 69 95 -65 61 122 136 90 85 99
Total Gross Profit
355 384 369 393 356 351 427 449 399 409 437
Total Revenue
3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260 3,041 3,226
Operating Revenue
3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260 3,041 3,226
Total Cost of Revenue
3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861 2,632 2,789
Operating Cost of Revenue
3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861 2,632 2,789
Total Operating Expenses
259 295 300 298 421 289 304 313 309 323 339
Selling, General & Admin Expense
240 265 232 244 260 247 275 286 277 287 313
Depreciation Expense
7.33 9.40 12 12 13 13 11 11 11 10 5.99
Amortization Expense
9.80 16 19 18 20 19 18 17 16 19 17
Restructuring Charge
- - - 8.65 0.60 9.26 0.00 0.00 4.36 5.38 1.77
Other Special Charges / (Income)
1.29 5.21 37 15 6.94 0.52 - 0.00 0.00 1.90 1.07
Total Other Income / (Expense), net
-0.87 13 -5.96 -11 -6.81 -3.95 -3.54 -14 9.52 9.20 5.12
Interest Expense
2.12 3.22 9.12 13 12 6.93 6.52 20 13 8.01 6.59
Interest & Investment Income
3.45 5.33 3.71 1.82 5.83 3.10 4.33 7.41 9.38 11 12
Other Income / (Expense), net
-2.19 11 -0.55 0.25 -0.41 -0.12 -1.35 -1.66 13 5.96 -0.56
Income Tax Expense
32 32 28 19 7.45 12 30 34 23 23 25
Basic Earnings per Share
$2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10 $3.05 $3.69
Weighted Average Basic Shares Outstanding
26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M 23.44M 21.38M
Diluted Earnings per Share
$2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06 $3.00 $3.64
Weighted Average Diluted Shares Outstanding
26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M 23.84M 21.69M
Weighted Average Basic & Diluted Shares Outstanding
26.50M 25.30M 25.50M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M 21.88M 20.14M

Quarterly Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
13 16 17 17 17 20 20 16 17 26 8.69
Consolidated Net Income / (Loss)
13 16 17 17 17 20 20 16 17 26 8.69
Net Income / (Loss) Continuing Operations
13 16 17 17 17 20 20 16 17 26 8.69
Total Pre-Tax Income
18 23 23 20 24 27 27 19 24 33 12
Total Operating Income
18 22 18 18 22 27 26 18 23 32 12
Total Gross Profit
94 97 102 102 100 105 107 103 107 120 117
Total Revenue
753 746 776 747 705 813 740 767 767 953 962
Operating Revenue
753 746 776 747 705 813 740 767 767 953 962
Total Cost of Revenue
658 649 674 646 605 708 632 664 660 833 845
Operating Cost of Revenue
658 649 674 646 605 708 632 664 660 833 845
Total Operating Expenses
77 75 84 83 78 78 82 85 84 88 105
Selling, General & Admin Expense
67 68 72 74 70 72 75 78 78 82 97
Depreciation Expense
2.69 2.77 2.86 2.90 2.32 1.93 1.58 1.43 1.50 1.48 1.87
Amortization Expense
3.75 3.74 4.36 5.00 4.94 4.93 4.40 4.29 4.00 4.03 4.66
Restructuring Charge
3.92 - 5.07 0.31 0.00 - 0.00 0.00 0.00 1.77 1.65
Other Special Charges / (Income)
0.00 - 0.00 1.14 0.90 - 0.31 1.21 0.44 -0.89 -0.15
Total Other Income / (Expense), net
0.41 0.82 5.33 1.27 1.89 0.71 1.09 1.55 0.93 1.54 -0.47
Interest Expense
2.00 2.09 2.11 1.97 1.84 2.10 1.91 1.95 1.30 1.43 3.09
Interest & Investment Income
2.65 3.29 2.66 2.69 2.84 3.05 3.18 3.36 2.45 3.27 2.66
Other Income / (Expense), net
-0.24 -0.38 4.78 0.54 0.88 -0.25 -0.17 0.14 -0.22 -0.30 -0.05
Income Tax Expense
5.15 6.60 5.99 2.66 6.80 7.41 7.12 2.93 7.17 7.66 3.23
Basic Earnings per Share
$0.51 $0.66 $0.70 $0.72 $0.75 $0.88 $0.90 $0.75 $0.79 $1.25 $0.43
Weighted Average Basic Shares Outstanding
25.03M 24.87M 24.15M 23.81M 23.28M 23.44M 22.02M 21.87M 21.31M 21.38M 20.22M
Diluted Earnings per Share
$0.50 $0.66 $0.69 $0.70 $0.74 $0.87 $0.89 $0.75 $0.78 $1.22 $0.42
Weighted Average Diluted Shares Outstanding
25.44M 25.22M 24.65M 24.22M 23.60M 23.84M 22.41M 22.11M 21.58M 21.69M 20.69M
Weighted Average Basic & Diluted Shares Outstanding
24.71M 24.03M 0.00 23.46M 22.60M 21.88M 21.94M 21.48M 20.32M 20.14M 20.33M

Annual Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents
-60 -4.87 -35 -1.71 11 28 -25 -1.81 149 -59 -38
Net Cash From Operating Activities
52 95 25 16 182 117 -124 -36 372 112 123
Net Cash From Continuing Operating Activities
52 95 31 16 182 117 -124 -36 372 112 123
Net Income / (Loss) Continuing Operations
64 69 35 65 -79 45 89 88 77 72 79
Consolidated Net Income / (Loss)
64 69 33 58 -193 11 89 90 77 72 79
Depreciation Expense
17 25 34 34 35 34 30 29 28 30 24
Amortization Expense
0.30 0.29 0.33 0.35 0.42 0.42 0.42 0.58 0.39 0.39 0.62
Non-Cash Adjustments To Reconcile Net Income
15 15 9.44 -2.43 125 5.96 13 14 3.80 19 20
Changes in Operating Assets and Liabilities, net
-43 -15 -48 -80 101 31 -257 -167 262 -9.28 -0.06
Net Cash From Investing Activities
-74 -96 -152 -38 -55 32 -3.72 -8.26 9.05 -62 -28
Net Cash From Continuing Investing Activities
-74 -96 -151 -38 -55 32 -3.72 -8.26 9.05 -62 -28
Purchase of Property, Plant & Equipment
-12 -8.85 -7.00 -5.80 -6.39 -2.36 -6.85 -9.98 -8.56 -8.29 -9.29
Acquisitions
-61 -87 -144 -32 -49 - - 0.00 0.00 -57 -18
Divestitures
- - - 0.00 0.00 34 3.13 1.72 18 2.57 0.00
Net Cash From Financing Activities
-36 -3.51 101 31 -153 -119 108 40 -228 -111 -134
Net Cash From Continuing Financing Activities
-36 -3.51 101 31 -153 -119 108 40 -228 -111 -134
Repayment of Debt
-1,308 -1,794 -2,150 -2,134 -2,196 -1,957 -2,040 -2,442 -1,447 -61 -430
Repurchase of Common Equity
-100 -21 0.00 -9.48 -6.08 0.00 -18 -16 -43 -107 -98
Issuance of Debt
1,377 1,813 2,301 2,211 2,086 1,882 2,166 2,499 1,260 52 393
Other Financing Activities, net
-4.51 -1.94 -50 -36 -36 -43 -0.45 -1.55 1.94 4.62 0.55
Effect of Exchange Rate Changes
-2.60 - - 0.56 -3.64 3.71 -4.76 2.69 -3.64 1.64 1.07
Cash Interest Paid
1.71 2.83 8.61 13 12 6.41 6.07 19 13 7.57 6.10
Cash Income Taxes Paid
34 31 36 31 17 12 29 29 27 28 29

Quarterly Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
114 26 -40 -35 36 -20 -1.23 -41 37 -32 -43
Net Cash From Operating Activities
160 55 45 -6.19 66 7.65 23 31 71 -2.27 -42
Net Cash From Continuing Operating Activities
160 55 45 -6.19 66 7.65 23 31 71 -2.27 -42
Net Income / (Loss) Continuing Operations
13 16 17 17 17 20 20 16 17 26 8.69
Consolidated Net Income / (Loss)
13 16 17 17 17 20 20 16 17 26 8.69
Depreciation Expense
6.74 6.79 7.47 8.13 7.49 7.10 6.20 5.94 5.71 5.78 6.73
Amortization Expense
0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.34 0.09 0.09 0.09
Non-Cash Adjustments To Reconcile Net Income
3.80 4.67 4.17 7.29 4.69 3.34 4.82 7.33 3.77 4.16 10
Changes in Operating Assets and Liabilities, net
137 27 16 -39 36 -23 -7.78 0.75 45 -38 -68
Net Cash From Investing Activities
-2.42 -1.65 -59 0.77 -1.42 -2.52 -2.40 -20 -2.26 -2.52 -220
Net Cash From Continuing Investing Activities
-2.42 -1.65 -59 0.77 -1.42 -2.52 -2.40 -20 -2.26 -2.52 -220
Purchase of Property, Plant & Equipment
-2.42 -1.27 -2.38 -1.97 -1.42 -2.52 -2.40 -1.98 -2.40 -2.52 -1.84
Acquisitions
- - -57 0.18 - - 0.00 -18 0.14 - -218
Net Cash From Financing Activities
-43 -24 -27 -26 -31 -27 -23 -50 -34 -27 219
Net Cash From Continuing Financing Activities
-43 -24 -27 -26 -31 -27 -23 -50 -34 -27 219
Repayment of Debt
-131 -19 -9.06 -22 -14 -16 -52 -225 -48 -105 -519
Repurchase of Common Equity
-20 -22 -28 -24 -29 -25 -21 -17 -33 -27 -4.80
Issuance of Debt
108 17 8.38 18 12 14 49 193 48 104 749
Other Financing Activities, net
0.18 0.11 2.18 2.51 0.00 -0.07 0.84 0.00 -0.22 -0.07 -6.71
Other Net Changes in Cash
- - - - - - - - - - -0.05

Annual Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets
1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779 1,786 1,932
Total Current Assets
1,229 1,281 1,362 1,477 1,203 1,220 1,524 1,657 1,405 1,370 1,508
Cash & Equivalents
61 56 26 19 29 63 38 36 185 126 88
Accounts Receivable
560 637 646 523 443 569 729 753 582 636 770
Inventories, net
559 531 596 554 455 470 615 758 513 484 522
Prepaid Expenses
49 56 95 84 95 118 142 110 125 122 117
Current Deferred & Refundable Income Taxes
- - - - - - - - - 2.82 11
Plant, Property, & Equipment, net
52 57 73 0.00 0.00 0.00 0.00 0.00 34 31 35
Total Noncurrent Assets
210 381 510 590 489 452 414 411 341 384 390
Goodwill
93 201 298 311 214 219 214 217 206 231 245
Intangible Assets
51 102 137 121 122 105 84 68 38 63 64
Noncurrent Deferred & Refundable Income Taxes
29 29 22 15 25 22 16 18 20 19 11
Other Noncurrent Operating Assets
37 49 53 113 128 106 99 108 77 71 70
Total Liabilities & Shareholders' Equity
1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779 1,786 1,932
Total Liabilities
717 881 1,079 1,153 1,014 940 1,131 1,163 855 879 1,022
Total Current Liabilities
585 656 710 701 719 733 814 787 669 683 859
Short-Term Debt
12 31 44 42 54 7.84 12 6.92 7.86 9.18 19
Accounts Payable
471 513 563 488 454 635 714 691 588 599 753
Current Deferred & Payable Income Tax Liabilities
3.06 7.73 13 3.96 5.89 2.50 0.03 9.88 7.90 3.93 0.47
Other Current Liabilities
99 105 91 65 77 88 88 79 66 71 87
Total Noncurrent Liabilities
132 225 369 452 295 208 317 376 185 196 162
Long-Term Debt
77 97 249 323 211 135 260 323 136 128 99
Noncurrent Deferred & Payable Income Tax Liabilities
2.56 2.01 1.77 0.00 3.88 3.95 3.14 3.82 - - 0.00
Other Noncurrent Operating Liabilities
52 126 118 97 80 68 54 49 49 68 64
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
774 837 866 914 678 731 807 905 924 906 911
Total Preferred & Common Equity
774 837 866 914 678 731 807 905 924 906 911
Preferred Stock
- - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
774 837 866 914 678 731 807 905 924 906 911
Common Stock
67 61 68 64 64 71 64 58 26 0.00 0.00
Retained Earnings
780 849 882 940 747 758 847 937 1,014 1,021 1,018
Accumulated Other Comprehensive Income / (Loss)
-73 -73 -84 -90 -133 -98 -105 -90 -116 -114 -107

Quarterly Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 3/31/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026 9/30/2026
Total Assets
1,980 1,899 1,781 1,783 1,787 1,703 1,725 1,717 1,742 1,806 2,233
Total Current Assets
1,578 1,507 1,405 1,416 1,352 1,284 1,310 1,307 1,303 1,372 1,544
Cash & Equivalents
37 43 45 159 145 111 146 125 83 120 46
Accounts Receivable
684 692 663 590 567 549 563 557 605 628 815
Inventories, net
753 656 575 529 504 492 476 505 490 487 548
Prepaid Expenses
103 117 122 138 136 132 125 120 113 126 125
Current Deferred & Refundable Income Taxes
- - - - - - - - 11 10 9.75
Plant, Property, & Equipment, net
36 0.00 0.00 36 33 30 30 32 32 34 35
Total Noncurrent Assets
366 391 376 331 401 389 385 377 406 400 654
Goodwill
215 215 208 208 233 228 229 231 244 245 344
Intangible Assets
72 64 45 42 78 73 68 59 72 68 237
Noncurrent Deferred & Refundable Income Taxes
14 16 19 19 17 18 18 17 14 16 3.22
Other Noncurrent Operating Assets
65 96 103 63 73 70 70 71 76 71 70
Total Liabilities & Shareholders' Equity
1,980 1,899 1,781 1,783 1,787 1,703 1,725 1,717 1,742 1,806 2,233
Total Liabilities
1,101 983 827 839 866 802 823 803 831 899 1,317
Total Current Liabilities
744 701 611 643 666 610 632 606 664 737 883
Short-Term Debt
5.98 8.21 7.86 7.86 12 9.90 9.60 9.65 19 19 17
Accounts Payable
657 618 541 556 579 520 541 530 577 647 775
Current Deferred & Payable Income Tax Liabilities
4.44 8.11 3.65 4.79 6.38 8.33 13 3.56 0.27 0.28 0.48
Other Current Liabilities
77 67 58 75 69 71 68 63 68 71 91
Total Noncurrent Liabilities
357 282 217 196 200 192 192 197 167 163 434
Long-Term Debt
305 240 161 138 134 132 130 126 100 99 329
Noncurrent Deferred & Payable Income Tax Liabilities
3.20 3.68 0.00 0.00 - - - - - - 39
Other Noncurrent Operating Liabilities
49 39 56 58 66 60 61 71 67 64 66
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
879 915 954 944 921 901 902 914 911 906 916
Total Preferred & Common Equity
879 915 954 944 921 901 902 914 911 906 916
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
879 915 954 944 921 901 902 914 911 906 916
Common Stock
60 60 64 46 2.98 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
918 952 985 998 1,031 1,032 1,023 1,025 1,027 1,015 1,023
Accumulated Other Comprehensive Income / (Loss)
-99 -96 -95 -100 -113 -131 -122 -111 -116 -109 -107

Annual Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding
- - - - - - - - - - 20,324,529.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 20,324,529.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.88
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.99% 0.79% -11.31% 2.69% -6.22% 3.38% 12.03% 7.30% -13.94% -6.72% 6.09%
EBITDA Growth
0.70% 11.15% -17.14% 24.89% -122.97% 421.57% 58.58% 8.14% -19.29% -7.69% 0.47%
EBIT Growth
-4.42% 4.96% -31.11% 38.74% -168.83% 193.86% 96.87% 11.10% -22.90% -11.91% 7.58%
NOPAT Growth
-3.36% -6.22% -35.54% 89.31% -161.90% 206.66% 88.33% 7.54% -29.04% -7.37% 16.11%
Net Income Growth
-2.75% 8.84% -52.12% 73.73% -434.49% 105.60% 722.58% 1.14% -14.20% -7.15% 10.24%
EPS Growth
4.85% 13.87% -52.40% 73.64% -438.84% 105.53% 721.43% 2.61% -13.56% -1.96% 21.33%
Operating Cash Flow Growth
-30.87% 81.72% -73.85% -35.37% 1,035.44% -35.85% -206.50% 71.24% 1,139.02% -69.77% 9.60%
Free Cash Flow Firm Growth
-58.51% -48.69% -292.19% 174.51% 17.60% -40.01% -240.26% 55.33% 731.87% -92.30% 78.00%
Invested Capital Growth
13.60% 13.41% 24.67% -5.71% -19.46% -5.69% 28.10% 15.32% -26.37% 3.95% 2.41%
Revenue Q/Q Growth
0.59% 1.13% -16.05% 0.78% 10.87% 7.37% 3.20% -0.40% -5.81% 2.25% 4.54%
EBITDA Q/Q Growth
-5.16% 4.66% -0.64% 3.06% -127.79% 332.09% 2.03% -0.16% -4.28% 4.60% 3.00%
EBIT Q/Q Growth
-6.64% 4.05% -1.01% 4.42% -188.87% 181.14% 2.89% 0.15% -4.99% 5.86% 5.25%
NOPAT Q/Q Growth
-4.95% 8.26% -11.92% 12.45% -180.86% 192.09% -0.06% -1.05% -6.15% 6.68% 6.91%
Net Income Q/Q Growth
-5.25% 9.56% -20.56% 2.11% -632.38% 104.69% -4.07% -1.25% -3.40% 5.91% 7.54%
EPS Q/Q Growth
-2.86% 9.27% -20.37% 2.28% -634.51% 104.63% -4.43% -0.56% -3.16% 7.53% 10.64%
Operating Cash Flow Q/Q Growth
-28.18% -15.31% 448.56% 147.06% 22.45% -9.74% -893.38% 63.94% 23.21% -29.54% -7.45%
Free Cash Flow Firm Q/Q Growth
-119.98% -76.21% 19.25% 393.62% 55.20% -71.04% -942.69% 43.81% 30.38% -69.12% -13.27%
Invested Capital Q/Q Growth
-0.96% 1.94% -2.76% -16.37% -29.99% -3.39% 10.07% 4.03% -5.16% 2.51% 3.92%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
10.04% 10.75% 11.67% 12.09% 11.67% 11.13% 12.08% 11.86% 12.24% 13.44% 13.56%
EBITDA Margin
3.17% 3.49% 3.26% 3.97% -0.97% 3.02% 4.28% 4.31% 4.05% 4.00% 3.79%
Operating Margin
2.74% 2.47% 2.18% 2.92% -2.13% 1.95% 3.46% 3.59% 2.77% 2.80% 3.06%
EBIT Margin
2.67% 2.79% 2.16% 2.92% -2.15% 1.95% 3.42% 3.54% 3.17% 3.00% 3.04%
Profit (Net Income) Margin
1.80% 1.94% 1.05% 1.77% -6.32% 0.34% 2.52% 2.37% 2.36% 2.35% 2.44%
Tax Burden Percent
66.26% 68.23% 52.58% 68.87% 268.41% 18.76% 74.86% 73.70% 77.18% 75.80% 76.03%
Interest Burden Percent
101.40% 102.13% 92.10% 88.06% 109.79% 93.76% 98.19% 90.78% 96.47% 103.55% 105.78%
Effective Tax Rate
33.74% 31.77% 43.76% 22.45% 0.00% 21.11% 25.23% 27.70% 22.82% 24.20% 23.97%
Return on Invested Capital (ROIC)
8.52% 7.04% 3.80% 6.67% -4.71% 5.80% 9.87% 8.78% 6.70% 7.17% 8.07%
ROIC Less NNEP Spread (ROIC-NNEP)
10.02% 25.32% 0.46% -0.86% -92.11% -22.89% 8.24% 5.58% 12.52% -39.15% 27.36%
Return on Net Nonoperating Assets (RNNOA)
-0.48% 1.55% 0.09% -0.20% -19.48% -4.27% 1.68% 1.72% 1.73% 0.64% 0.61%
Return on Equity (ROE)
8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42% 7.82% 8.68%
Cash Return on Invested Capital (CROIC)
-4.22% -5.53% -18.16% 12.55% 16.84% 11.66% -14.77% -5.46% 37.07% 3.30% 5.69%
Operating Return on Assets (OROA)
6.38% 6.19% 3.74% 4.73% -3.48% 3.65% 6.69% 6.70% 5.38% 5.11% 5.28%
Return on Assets (ROA)
4.29% 4.32% 1.81% 2.87% -10.25% 0.64% 4.92% 4.48% 4.01% 4.01% 4.24%
Return on Common Equity (ROCE)
8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42% 7.82% 8.68%
Return on Equity Simple (ROE_SIMPLE)
8.21% 8.27% 3.83% 6.30% -28.40% 1.48% 11.01% 9.92% 8.34% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
64 60 39 73 -45 49 91 98 70 65 75
NOPAT Margin
1.81% 1.69% 1.23% 2.26% -1.49% 1.54% 2.59% 2.59% 2.14% 2.12% 2.32%
Net Nonoperating Expense Percent (NNEP)
-1.50% -18.28% 3.34% 7.53% 87.40% 28.69% 1.63% 3.20% -5.82% 46.32% -19.29%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 6.19% 7.29%
Cost of Revenue to Revenue
89.96% 89.25% 88.33% 87.91% 88.33% 88.87% 87.92% 88.14% 87.76% 86.56% 86.44%
SG&A Expenses to Revenue
6.78% 7.43% 7.34% 7.52% 8.52% 7.85% 7.80% 7.54% 8.51% 9.44% 9.71%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
7.30% 8.28% 9.49% 9.17% 13.80% 9.18% 8.62% 8.27% 9.47% 10.64% 10.50%
Earnings before Interest and Taxes (EBIT)
95 99 68 95 -65 61 121 134 103 91 98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
112 125 103 129 -30 95 151 163 132 122 122
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.23 1.22 1.19 0.92 0.90 0.98 0.97 0.81 1.18 1.04 1.16
Price to Tangible Book Value (P/TBV)
1.51 1.91 2.39 1.74 1.78 1.76 1.55 1.19 1.61 1.54 1.76
Price to Revenue (P/Rev)
0.27 0.29 0.33 0.26 0.20 0.23 0.22 0.19 0.34 0.31 0.33
Price to Earnings (P/E)
14.97 14.73 31.08 14.53 0.00 66.36 8.85 8.20 14.21 13.20 13.42
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
6.68% 6.79% 3.22% 6.88% 0.00% 1.51% 11.30% 12.20% 7.04% 7.57% 7.45%
Enterprise Value to Invested Capital (EV/IC)
1.22 1.20 1.14 1.11 0.98 0.98 0.98 0.86 1.19 1.04 1.16
Enterprise Value to Revenue (EV/Rev)
0.28 0.31 0.41 0.36 0.28 0.25 0.29 0.27 0.32 0.31 0.34
Enterprise Value to EBITDA (EV/EBITDA)
8.73 8.76 12.56 9.18 0.00 8.36 6.74 6.30 7.99 7.85 8.89
Enterprise Value to EBIT (EV/EBIT)
10.34 10.99 18.95 12.46 0.00 12.98 8.43 7.67 10.18 10.49 11.09
Enterprise Value to NOPAT (EV/NOPAT)
15.26 18.14 33.43 16.11 0.00 16.43 11.15 10.48 15.11 14.80 14.51
Enterprise Value to Operating Cash Flow (EV/OCF)
18.76 11.51 52.30 73.82 4.65 6.82 0.00 0.00 2.83 8.51 8.83
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 8.57 5.21 8.18 0.00 0.00 2.73 32.18 20.57
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.11 0.15 0.34 0.40 0.39 0.20 0.34 0.36 0.16 0.15 0.13
Long-Term Debt to Equity
0.10 0.12 0.29 0.35 0.31 0.19 0.32 0.36 0.15 0.14 0.11
Financial Leverage
-0.05 0.06 0.20 0.24 0.21 0.19 0.20 0.31 0.14 -0.02 0.02
Leverage Ratio
1.87 1.99 2.15 2.25 2.36 2.39 2.35 2.34 2.10 1.95 2.05
Compound Leverage Factor
1.90 2.03 1.98 1.98 2.59 2.24 2.30 2.12 2.03 2.02 2.16
Debt to Total Capital
10.25% 13.26% 25.23% 28.58% 28.10% 16.37% 25.16% 26.71% 13.48% 13.17% 11.42%
Short-Term Debt to Total Capital
1.34% 3.18% 3.76% 3.32% 5.74% 0.90% 1.08% 0.56% 0.74% 0.88% 1.83%
Long-Term Debt to Total Capital
8.91% 10.08% 21.48% 25.27% 22.36% 15.48% 24.09% 26.15% 12.74% 12.29% 9.58%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
89.75% 86.74% 74.77% 71.42% 71.90% 83.63% 74.84% 73.29% 86.52% 86.83% 88.58%
Debt to EBITDA
0.79 1.03 2.83 2.84 -8.94 1.50 1.79 2.02 1.09 1.13 0.96
Net Debt to EBITDA
0.24 0.58 2.58 2.69 -7.95 0.84 1.54 1.80 -0.31 0.09 0.24
Long-Term Debt to EBITDA
0.69 0.78 2.41 2.51 -7.12 1.42 1.72 1.98 1.03 1.05 0.81
Debt to NOPAT
1.38 2.13 7.54 4.98 -5.83 2.95 2.97 3.36 2.07 2.13 1.57
Net Debt to NOPAT
0.42 1.19 6.88 4.72 -5.18 1.66 2.55 2.99 -0.59 0.18 0.39
Long-Term Debt to NOPAT
1.20 1.62 6.41 4.40 -4.64 2.79 2.84 3.29 1.95 1.99 1.31
Altman Z-Score
4.63 4.09 3.35 3.25 3.00 3.45 3.50 3.56 4.09 3.78 3.60
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.10 1.95 1.92 2.11 1.67 1.66 1.87 2.11 2.10 2.01 1.76
Quick Ratio
1.06 1.06 0.95 0.77 0.66 0.86 0.94 1.00 1.15 1.12 1.00
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-32 -47 -185 138 162 97 -137 -61 386 30 53
Operating Cash Flow to CapEx
432.17% 1,072.17% 354.47% 276.56% 2,850.05% 4,941.47% -1,815.65% -358.44% 4,344.21% 1,355.89% 1,325.99%
Free Cash Flow to Firm to Interest Expense
-14.97 -14.71 -20.33 10.50 13.29 14.07 -20.96 -3.09 29.61 3.71 8.02
Operating Cash Flow to Interest Expense
24.58 29.51 2.72 1.22 14.89 16.85 -19.06 -1.81 28.52 14.02 18.68
Operating Cash Flow Less CapEx to Interest Expense
18.89 26.76 1.95 0.78 14.37 16.51 -20.11 -2.31 27.86 12.99 17.27
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.39 2.22 1.73 1.62 1.62 1.87 1.96 1.89 1.69 1.71 1.74
Accounts Receivable Turnover
6.54 5.96 4.93 5.56 6.31 6.23 5.44 5.11 4.88 5.00 4.59
Inventory Turnover
5.73 5.84 4.96 4.97 5.34 6.05 5.72 4.87 4.50 5.28 5.54
Fixed Asset Turnover
71.55 65.50 48.84 0.00 0.00 0.00 0.00 0.00 0.00 94.04 97.72
Accounts Payable Turnover
6.55 6.47 5.20 5.44 5.71 5.14 4.60 4.75 4.47 4.44 4.13
Days Sales Outstanding (DSO)
55.78 61.21 74.01 65.68 57.88 58.63 67.13 71.44 74.73 73.04 79.50
Days Inventory Outstanding (DIO)
63.70 62.46 73.59 73.46 68.40 60.29 63.80 75.02 81.03 69.09 65.85
Days Payable Outstanding (DPO)
55.75 56.43 70.23 67.13 63.89 70.98 79.33 76.82 81.60 82.27 88.47
Cash Conversion Cycle (CCC)
63.74 67.25 77.37 72.01 62.38 47.93 51.60 69.64 74.16 59.86 56.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
802 909 1,133 1,069 861 812 1,040 1,199 883 918 940
Invested Capital Turnover
4.70 4.17 3.10 2.95 3.16 3.77 3.81 3.38 3.13 3.38 3.47
Increase / (Decrease) in Invested Capital
96 107 224 -65 -208 -49 228 159 -316 35 22
Enterprise Value (EV)
979 1,092 1,297 1,184 846 797 1,019 1,030 1,053 956 1,088
Market Capitalization
952 1,020 1,031 837 611 716 786 736 1,095 945 1,059
Book Value per Share
$30.18 $33.07 $33.88 $35.56 $26.76 $28.71 $31.96 $36.36 $37.41 $40.11 $44.81
Tangible Book Value per Share
$24.57 $21.12 $16.87 $18.76 $13.51 $16.00 $20.12 $24.90 $27.53 $27.12 $29.59
Total Capital
863 965 1,159 1,280 943 874 1,078 1,235 1,068 1,044 1,028
Total Debt
88 128 292 366 265 143 271 330 144 137 117
Total Long-Term Debt
77 97 249 323 211 135 260 323 136 128 99
Net Debt
27 72 267 347 236 80 233 294 -41 11 29
Capital Expenditures (CapEx)
12 8.85 7.00 5.80 6.39 2.36 6.85 9.98 8.56 8.29 9.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)
594 599 670 800 509 432 683 841 558 571 579
Debt-free Net Working Capital (DFNWC)
655 655 695 819 539 495 721 877 743 697 668
Net Working Capital (NWC)
644 625 652 776 484 487 710 870 735 687 649
Net Nonoperating Expense (NNE)
0.57 -9.04 5.65 16 147 38 2.55 8.43 -7.35 -6.97 -3.89
Net Nonoperating Obligations (NNO)
27 72 267 154 182 80 233 294 -41 11 29
Total Depreciation and Amortization (D&A)
17 25 35 34 36 34 30 29 28 31 24
Debt-free, Cash-free Net Working Capital to Revenue
16.78% 16.80% 21.17% 24.60% 16.71% 13.71% 19.35% 22.20% 17.11% 18.76% 17.96%
Debt-free Net Working Capital to Revenue
18.51% 18.37% 21.97% 25.20% 17.67% 15.70% 20.43% 23.16% 22.80% 22.91% 20.70%
Net Working Capital to Revenue
18.19% 17.51% 20.60% 23.89% 15.90% 15.45% 20.10% 22.98% 22.56% 22.61% 20.11%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10 $3.05 $3.69
Adjusted Weighted Average Basic Shares Outstanding
26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M 23.44M 21.38M
Adjusted Diluted Earnings per Share
$2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06 $3.00 $3.64
Adjusted Weighted Average Diluted Shares Outstanding
26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M 23.84M 21.69M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
25.63M 25.43M 25.59M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M 21.88M 20.14M
Normalized Net Operating Profit after Tax (NOPAT)
65 64 60 92 44 56 91 98 73 70 77
Normalized NOPAT Margin
1.84% 1.79% 1.88% 2.83% 1.45% 1.78% 2.59% 2.59% 2.24% 2.31% 2.39%
Pre Tax Income Margin
2.71% 2.84% 1.99% 2.57% -2.36% 1.83% 3.36% 3.22% 3.06% 3.10% 3.22%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
44.58 30.91 7.51 7.22 -5.35 8.86 18.52 6.78 7.94 11.38 14.88
NOPAT to Interest Expense
30.22 18.73 4.25 5.58 -3.72 7.00 14.00 4.97 5.35 8.06 11.37
EBIT Less CapEx to Interest Expense
38.89 28.16 6.74 6.78 -5.87 8.52 17.47 6.28 7.29 10.34 13.47
NOPAT Less CapEx to Interest Expense
24.54 15.97 3.49 5.14 -4.24 6.66 12.95 4.46 4.69 7.03 9.96
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
157.51% 30.16% 0.00% 16.46% -3.15% 0.00% 20.50% 17.43% 55.66% 148.88% 124.12%

Quarterly Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 21,480,385.00 20,324,529.00 20,142,812.00
DEI Adjusted Shares Outstanding
- - - - - - - - 21,480,385.00 20,324,529.00 20,142,812.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.79 1.26 0.43
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-15.01% -21.23% -11.49% -15.52% -6.34% 8.95% -4.63% 2.54% 8.79% 17.25% 30.10%
EBITDA Growth
-41.25% -17.21% -2.41% -44.05% 27.63% 18.86% 6.83% -10.79% -6.82% 10.57% -40.14%
EBIT Growth
-48.99% -20.20% -4.25% -54.01% 34.22% 23.47% 14.80% -5.18% -1.37% 18.43% -52.02%
NOPAT Growth
-48.54% -21.98% -32.86% -27.21% 28.45% 26.17% 46.35% -4.91% 0.98% 24.85% -52.62%
Net Income Growth
-39.65% -14.44% 9.99% -47.89% 36.12% 24.81% 17.11% -3.28% -3.13% 27.51% -56.28%
EPS Growth
-39.76% -13.16% 13.11% -45.74% 48.00% 31.82% 28.99% 7.14% 5.41% 40.23% -52.81%
Operating Cash Flow Growth
192.04% 458.69% -52.07% -109.79% -58.75% -86.03% -48.22% 598.40% 8.01% -129.72% -282.26%
Free Cash Flow Firm Growth
227.53% 337.89% 1,720.44% 30.56% -77.91% -104.61% -92.62% -99.55% -86.33% 115.25% -1,899.34%
Invested Capital Growth
-19.23% -26.37% -17.78% -13.48% -3.83% 3.95% 0.37% 1.55% 1.02% 2.41% 31.48%
Revenue Q/Q Growth
-14.94% -0.86% 3.95% -3.62% -5.71% 15.33% -9.01% 3.63% 0.04% 24.30% 0.96%
EBITDA Q/Q Growth
-50.37% 17.59% 5.61% -9.22% 13.20% 9.51% -5.08% -24.19% 18.24% 29.95% -48.61%
EBIT Q/Q Growth
-58.09% 24.25% 4.26% -15.28% 22.30% 14.30% -3.06% -30.03% 27.22% 37.24% -60.72%
NOPAT Q/Q Growth
-42.92% 23.96% -15.98% 22.45% 0.72% 21.76% -2.54% -20.44% 6.96% 50.54% -63.01%
Net Income Q/Q Growth
-60.87% 25.69% 5.45% 0.47% 2.22% 15.25% -1.06% -17.03% 2.38% 51.71% -66.07%
EPS Q/Q Growth
-61.24% 32.00% 4.55% 1.45% 5.71% 17.57% 2.30% -15.73% 4.00% 56.41% -65.57%
Operating Cash Flow Q/Q Growth
153.31% -65.82% -18.10% -113.80% 1,167.58% -88.43% 203.61% 32.87% 131.35% -103.18% -1,761.97%
Free Cash Flow Firm Q/Q Growth
89.78% 41.62% -35.98% -24.12% -67.89% -129.57% 202.48% -95.38% 876.71% -67.02% -12,191.54%
Invested Capital Q/Q Growth
-13.59% -5.16% 4.37% 1.16% -3.95% 2.51% 0.77% 2.35% -4.45% 3.92% 29.38%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
12.55% 13.04% 13.10% 13.61% 14.22% 12.93% 14.53% 13.43% 13.97% 12.57% 12.15%
EBITDA Margin
3.21% 3.80% 3.87% 3.64% 4.37% 4.15% 4.33% 3.17% 3.74% 3.91% 1.99%
Operating Margin
2.33% 2.93% 2.27% 2.47% 3.17% 3.30% 3.50% 2.33% 3.02% 3.33% 1.29%
EBIT Margin
2.30% 2.88% 2.89% 2.54% 3.29% 3.27% 3.48% 2.35% 2.99% 3.30% 1.28%
Profit (Net Income) Margin
1.70% 2.16% 2.19% 2.28% 2.47% 2.47% 2.69% 2.15% 2.20% 2.69% 0.90%
Tax Burden Percent
71.33% 70.92% 73.92% 86.52% 71.95% 73.06% 73.63% 84.92% 70.20% 76.99% 72.92%
Interest Burden Percent
103.76% 105.58% 102.45% 103.81% 104.33% 103.60% 104.92% 107.87% 105.01% 105.85% 96.54%
Effective Tax Rate
28.67% 29.08% 26.08% 13.48% 28.05% 26.94% 26.37% 15.08% 29.80% 23.01% 27.08%
Return on Invested Capital (ROIC)
5.52% 6.51% 5.20% 6.42% 7.43% 8.13% 8.39% 6.37% 7.26% 8.90% 3.03%
ROIC Less NNEP Spread (ROIC-NNEP)
5.75% 6.97% 9.03% 7.83% -6.36% 4.68% 22.65% 10.31% -8.30% 14.78% 2.80%
Return on Net Nonoperating Assets (RNNOA)
0.82% 0.96% 1.01% 0.66% 0.07% -0.08% 0.14% 0.38% 0.04% 0.33% 0.48%
Return on Equity (ROE)
6.35% 7.47% 6.21% 7.08% 7.50% 8.05% 8.53% 6.75% 7.30% 9.23% 3.50%
Cash Return on Invested Capital (CROIC)
28.41% 37.07% 25.75% 20.12% 10.54% 3.30% 7.29% 5.91% 6.78% 5.69% -21.13%
Operating Return on Assets (OROA)
4.23% 4.88% 4.95% 4.41% 5.59% 5.57% 5.97% 4.12% 5.22% 5.72% 2.24%
Return on Assets (ROA)
3.13% 3.66% 3.75% 3.96% 4.19% 4.22% 4.61% 3.78% 3.85% 4.66% 1.58%
Return on Common Equity (ROCE)
6.35% 7.47% 6.21% 7.08% 7.50% 8.05% 8.53% 6.75% 7.30% 9.23% 3.50%
Return on Equity Simple (ROE_SIMPLE)
8.45% 0.00% 8.54% 6.99% 7.49% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
13 16 13 16 16 20 19 15 16 24 9.04
NOPAT Margin
1.66% 2.08% 1.68% 2.13% 2.28% 2.41% 2.58% 1.98% 2.12% 2.56% 0.94%
Net Nonoperating Expense Percent (NNEP)
-0.22% -0.46% -3.83% -1.41% 13.79% 3.45% -14.26% -3.93% 15.56% -5.87% 0.22%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.53% 1.54% 1.87% 1.82% 1.47% 1.58% 2.38% 0.72%
Cost of Revenue to Revenue
87.45% 86.96% 86.90% 86.39% 85.78% 87.07% 85.47% 86.57% 86.03% 87.43% 87.85%
SG&A Expenses to Revenue
8.85% 9.18% 9.25% 9.89% 9.89% 8.81% 10.18% 10.19% 10.18% 8.57% 10.03%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.22% 10.11% 10.83% 11.14% 11.05% 9.63% 11.03% 11.09% 10.96% 9.24% 10.86%
Earnings before Interest and Taxes (EBIT)
17 21 22 19 23 27 26 18 23 31 12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
24 28 30 27 31 34 32 24 29 37 19
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.17 1.18 1.25 0.00 0.88 1.04 1.05 0.94 0.86 1.16 1.29
Price to Tangible Book Value (P/TBV)
1.60 1.61 1.89 0.00 1.32 1.54 1.54 1.44 1.32 1.76 3.53
Price to Revenue (P/Rev)
0.32 0.34 0.37 0.00 0.27 0.31 0.32 0.28 0.25 0.33 0.34
Price to Earnings (P/E)
13.90 14.21 14.68 0.00 11.81 13.20 12.93 11.60 10.63 13.42 17.48
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
7.20% 7.04% 6.81% 0.00% 8.47% 7.57% 7.73% 8.62% 9.41% 7.45% 5.72%
Enterprise Value to Invested Capital (EV/IC)
1.18 1.19 1.25 0.00 0.88 1.04 1.05 0.94 0.86 1.16 1.22
Enterprise Value to Revenue (EV/Rev)
0.32 0.32 0.37 0.00 0.27 0.31 0.32 0.30 0.25 0.34 0.43
Enterprise Value to EBITDA (EV/EBITDA)
7.95 7.99 8.80 0.00 6.80 7.85 7.86 7.39 6.55 8.89 13.55
Enterprise Value to EBIT (EV/EBIT)
10.06 10.18 11.27 0.00 9.19 10.49 10.30 9.55 8.35 11.09 17.51
Enterprise Value to NOPAT (EV/NOPAT)
14.75 15.11 18.16 0.00 13.07 14.80 13.77 12.76 11.09 14.51 22.83
Enterprise Value to Operating Cash Flow (EV/OCF)
3.63 2.83 3.58 0.00 4.96 8.51 10.73 6.99 5.85 8.83 25.74
Enterprise Value to Free Cash Flow (EV/FCFF)
3.70 2.73 4.39 0.00 8.23 32.18 14.46 16.09 12.76 20.57 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.15 0.16 0.16 0.16 0.16 0.15 0.15 0.13 0.13 0.13 0.38
Long-Term Debt to Equity
0.15 0.15 0.15 0.15 0.14 0.14 0.14 0.11 0.11 0.11 0.36
Financial Leverage
0.14 0.14 0.11 0.08 -0.01 -0.02 0.01 0.04 0.00 0.02 0.17
Leverage Ratio
2.06 2.10 2.01 1.88 1.90 1.95 1.91 1.90 1.95 2.05 2.16
Compound Leverage Factor
2.14 2.22 2.06 1.95 1.98 2.02 2.00 2.05 2.05 2.17 2.08
Debt to Total Capital
13.38% 13.48% 13.65% 13.61% 13.42% 13.17% 12.93% 11.56% 11.56% 11.42% 27.43%
Short-Term Debt to Total Capital
0.72% 0.74% 1.09% 0.95% 0.92% 0.88% 0.92% 1.88% 1.88% 1.83% 1.32%
Long-Term Debt to Total Capital
12.66% 12.74% 12.56% 12.66% 12.50% 12.29% 12.01% 9.69% 9.68% 9.58% 26.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
86.62% 86.52% 86.35% 86.39% 86.58% 86.83% 87.07% 88.44% 88.44% 88.58% 72.57%
Debt to EBITDA
1.06 1.09 1.11 1.29 1.20 1.13 1.10 0.99 1.00 0.96 3.16
Net Debt to EBITDA
-0.10 -0.31 0.00 0.29 -0.06 0.09 0.09 0.29 -0.02 0.24 2.74
Long-Term Debt to EBITDA
1.00 1.03 1.02 1.20 1.12 1.05 1.02 0.83 0.84 0.81 3.01
Debt to NOPAT
1.96 2.07 2.29 2.49 2.31 2.13 1.92 1.70 1.69 1.57 5.33
Net Debt to NOPAT
-0.18 -0.59 0.01 0.55 -0.11 0.18 0.15 0.51 -0.03 0.39 4.62
Long-Term Debt to NOPAT
1.86 1.95 2.11 2.32 2.15 1.99 1.78 1.43 1.41 1.31 5.07
Altman Z-Score
4.07 3.93 3.88 0.00 3.65 3.66 3.84 3.66 3.48 3.49 3.10
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.20 2.10 2.03 2.11 2.07 2.01 2.16 1.96 1.86 1.76 1.75
Quick Ratio
1.16 1.15 1.07 1.08 1.12 1.12 1.13 1.04 1.02 1.00 0.98
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
234 332 212 161 52 -15 16 0.72 7.07 2.33 -282
Operating Cash Flow to CapEx
6,617.81% 4,310.16% 1,887.58% -313.63% 4,648.98% 303.73% 969.14% 1,561.57% 2,974.20% -90.27% -2,296.63%
Free Cash Flow to Firm to Interest Expense
117.04 159.00 100.68 81.79 28.18 -7.29 8.19 0.37 5.43 1.63 -91.26
Operating Cash Flow to Interest Expense
80.04 26.24 21.26 -3.14 35.98 3.64 12.13 15.85 54.76 -1.59 -13.69
Operating Cash Flow Less CapEx to Interest Expense
78.83 25.63 20.13 -4.14 35.21 2.44 10.88 14.83 52.92 -3.35 -14.28
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.84 1.69 1.71 1.74 1.70 1.71 1.72 1.76 1.75 1.74 1.75
Accounts Receivable Turnover
5.43 4.88 5.02 4.99 5.16 5.00 5.35 5.24 5.18 4.59 5.03
Inventory Turnover
4.76 4.50 4.77 4.92 5.12 5.28 5.13 5.31 5.53 5.54 5.70
Fixed Asset Turnover
96.03 0.00 0.00 0.00 90.68 94.04 92.23 97.06 96.78 97.72 102.67
Accounts Payable Turnover
5.03 4.47 4.62 4.95 4.69 4.44 4.67 4.75 4.49 4.13 4.60
Days Sales Outstanding (DSO)
67.20 74.73 72.72 73.19 70.73 73.04 68.28 69.68 70.45 79.50 72.62
Days Inventory Outstanding (DIO)
76.69 81.03 76.58 74.14 71.30 69.09 71.12 68.73 65.98 65.85 64.03
Days Payable Outstanding (DPO)
72.54 81.60 78.96 73.72 77.77 82.27 78.08 76.76 81.37 88.47 79.29
Cash Conversion Cycle (CCC)
71.36 74.16 70.34 73.61 64.27 59.86 61.32 61.64 55.06 56.87 57.36
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
931 883 921 932 895 918 925 947 904 940 1,216
Invested Capital Turnover
3.32 3.13 3.09 3.01 3.26 3.38 3.26 3.22 3.43 3.47 3.22
Increase / (Decrease) in Invested Capital
-222 -316 -199 -145 -36 35 3.40 14 9.16 22 291
Enterprise Value (EV)
1,095 1,053 1,155 0.00 791 956 973 893 778 1,088 1,483
Market Capitalization
1,109 1,095 1,154 0.00 798 945 963 857 780 1,059 1,183
Book Value per Share
$37.51 $37.41 $38.32 $37.83 $38.43 $40.11 $41.77 $41.51 $42.19 $44.81 $45.46
Tangible Book Value per Share
$27.61 $27.53 $25.39 $25.21 $25.79 $27.12 $28.53 $27.08 $27.60 $29.59 $16.62
Total Capital
1,090 1,068 1,066 1,043 1,042 1,044 1,050 1,030 1,025 1,028 1,262
Total Debt
146 144 146 142 140 137 136 119 118 117 346
Total Long-Term Debt
138 136 134 132 130 128 126 100 99 99 329
Net Debt
-13 -41 0.52 31 -6.53 11 11 36 -1.88 29 300
Capital Expenditures (CapEx)
2.42 1.27 2.38 1.97 1.42 2.52 2.40 1.98 2.40 2.52 1.84
Debt-free, Cash-free Net Working Capital (DFCFNWC)
622 558 553 574 542 571 586 575 534 579 632
Debt-free Net Working Capital (DFNWC)
781 743 698 684 688 697 711 658 654 668 678
Net Working Capital (NWC)
773 735 686 674 678 687 701 639 635 649 661
Net Nonoperating Expense (NNE)
-0.29 -0.58 -3.94 -1.10 -1.36 -0.52 -0.80 -1.32 -0.65 -1.18 0.35
Net Nonoperating Obligations (NNO)
-13 -41 0.52 31 -6.53 11 11 36 -1.88 29 300
Total Depreciation and Amortization (D&A)
6.84 6.89 7.57 8.23 7.59 7.20 6.30 6.28 5.80 5.87 6.82
Debt-free, Cash-free Net Working Capital to Revenue
17.97% 17.11% 17.50% 18.98% 18.22% 18.76% 19.50% 19.00% 17.30% 17.96% 18.32%
Debt-free Net Working Capital to Revenue
22.57% 22.80% 22.10% 22.64% 23.13% 22.91% 23.66% 21.77% 21.20% 20.70% 19.65%
Net Working Capital to Revenue
22.34% 22.56% 21.73% 22.31% 22.81% 22.61% 23.33% 21.13% 20.58% 20.11% 19.17%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.51 $0.66 $0.70 $0.72 $0.75 $0.88 $0.90 $0.75 $0.79 $1.25 $0.43
Adjusted Weighted Average Basic Shares Outstanding
25.03M 24.87M 24.15M 23.81M 23.28M 23.44M 22.02M 21.87M 21.31M 21.38M 20.22M
Adjusted Diluted Earnings per Share
$0.50 $0.66 $0.69 $0.70 $0.74 $0.87 $0.89 $0.75 $0.78 $1.22 $0.42
Adjusted Weighted Average Diluted Shares Outstanding
25.44M 25.22M 24.65M 24.22M 23.60M 23.84M 22.41M 22.11M 21.58M 21.69M 20.69M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
24.71M 24.03M 0.00 23.46M 22.60M 21.88M 21.94M 21.48M 20.32M 20.14M 20.33M
Normalized Net Operating Profit after Tax (NOPAT)
15 16 17 17 17 20 19 16 17 25 10
Normalized NOPAT Margin
2.03% 2.08% 2.16% 2.30% 2.37% 2.41% 2.61% 2.11% 2.16% 2.63% 1.05%
Pre Tax Income Margin
2.39% 3.04% 2.96% 2.64% 3.44% 3.38% 3.65% 2.53% 3.14% 3.49% 1.24%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.65 10.31 10.63 9.64 12.65 12.65 13.44 9.25 17.58 21.98 3.99
NOPAT to Interest Expense
6.25 7.44 6.18 8.10 8.75 9.33 9.97 7.80 12.46 17.09 2.92
EBIT Less CapEx to Interest Expense
7.44 9.70 9.50 8.64 11.87 11.45 12.19 8.24 15.74 20.22 3.40
NOPAT Less CapEx to Interest Expense
5.04 6.83 5.05 7.10 7.98 8.13 8.71 6.78 10.62 15.33 2.33
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
32.72% 55.66% 90.36% 149.35% 152.45% 148.88% 133.89% 125.68% 131.77% 124.12% 120.28%

Financials Breakdown Chart

Key Financial Trends

ScanSource’s latest quarter shows a sharp increase in reported revenue, but weaker profitability and cash generation. The period also included a sizable acquisition funded largely with new borrowing, so the revenue and balance-sheet changes should not be viewed as purely organic growth. The figures below are quarterly and can fluctuate with working capital and deal activity.

  • Revenue rose year over year. Fiscal Q1 2027 revenue was $962.3 million, up from $739.7 million in Q1 2026. Gross profit also increased to $116.9 million from $107.5 million, although the acquisition makes it difficult to assess underlying growth from these figures alone.
  • ScanSource remains profitable. The company reported $8.7 million in net income and $0.42 in diluted earnings per share. Its weighted-average share count has generally declined from roughly 25 million in 2023 to about 20.7 million, which can support per-share results when earnings hold up.
  • The acquisition expanded the asset base. ScanSource spent $217.8 million on acquisitions in Q1 2027. Total assets rose to $2.23 billion from $1.81 billion in Q3 2026, while goodwill and intangible assets increased to a combined $580.9 million. The deal may create growth opportunities, but its returns and integration will matter.
  • Liquidity remains positive, but cash is lower. Cash was $45.9 million at September 30, 2026, down from $120.3 million at March 31, 2026. Current assets of $1.54 billion exceeded current liabilities of $883.0 million, leaving working capital of about $661 million.
  • Operating cash flow turned sharply negative. ScanSource used $42.3 million in operating cash in Q1 2027, compared with generating $23.2 million in Q1 2026. A $67.9 million use from changes in operating assets and liabilities was the main drag, highlighting the impact of working-capital swings.
  • Profitability weakened despite higher sales. Net income fell to $8.7 million from $19.9 million a year earlier, and diluted EPS declined to $0.42 from $0.89. Operating income was $12.4 million, down from $25.9 million in Q1 2026; higher selling, general and administrative costs contributed to the pressure.
  • Debt increased substantially. At quarter-end, short- and long-term debt totaled about $346.1 million, versus $118.4 million at March 31, 2026. Q1 financing included $749.5 million of debt issuance and $518.5 million of repayments, while cash from financing activities was $219.5 million. The larger borrowing adds interest and repayment obligations.
  • Working-capital balances warrant monitoring. Accounts receivable rose to $815.3 million from $628.4 million in Q3 2026, and inventory increased to $547.8 million from $486.6 million. If those balances do not convert into cash efficiently, they could continue to weigh on operating cash flow.
11/20/26 03:29 AM ETAI Generated. May Contain Errors.

ScanSource Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ScanSource's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

ScanSource's net income appears to be on an upward trend, with a most recent value of $78.87 million in 2026, rising from $63.62 million in 2016. The previous period was $71.55 million in 2025. View ScanSource's forecast to see where analysts expect ScanSource to go next.

ScanSource's total operating income in 2026 was $98.63 million, based on the following breakdown:
  • Total Gross Profit: $437.36 million
  • Total Operating Expenses: $338.73 million

Over the last 10 years, ScanSource's total revenue changed from $3.54 billion in 2016 to $3.23 billion in 2026, a change of -8.9%.

In the past 14 quarters, ScanSource's cash and equivalents has ranged from $37.37 million in Q3 2023 to $159.05 million in Q3 2024, and is currently $45.87 million as of their latest financial filing in Q1 2027.

ScanSource had total debt of $117.40 million at the end of 2026, a 14.6% decrease from 2025, and a 32.7% increase since 2016.

Over the last 10 years, ScanSource's book value per share changed from 30.18 in 2016 to 44.81 in 2026, a change of 48.5%.



Financial statements for NASDAQ:SCSC last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners